β-Lapachone-Induced Apoptosis is Associated with Inhibition of Cyclooxygenase-2 Activity in Human Lung Cancer A549 Cells

국문 초록 (Abstract)

β-lapachone은 남미에 자생하는 lapacho 나무(Tabeuia avellanedae)의 수액에 함유된 quinone계열의 일종으로 많은 인체암세포에서apoptosis를 유발하는 것으로 알려져 있다. 본 연구는 A549 인체폐암세포를 대상으로 β-lapachone에 의한 apoptosis 유발과정에서 나타나는 또 다른 현상들을 조사하기 위하여 실시되었다. β-lapachone이 처리된 A549 세포는 처리 농도의 증가에 따라 생존율이 감소되었으며, 이는 apoptosis 유발과 연관이 있음을 MTT assay와 flow cytometry 분석을 통하여 확인하였다. β-lapachone에 의한 A549 세포의 증식억제는 종양억제유전자 p53과 cyclin-dependent kinase 저해제인 p21의 발현을 전사 및 번역 수준에서 증가시켰으며, p53 단백질의 인산화 증가와 연관성이 있었다. 또한 β-lapachone은 caspase-3과 -9를 활성화시켰으며, 활성화된 caspase-3의 기질 단백질들[poly(ADP-ribose) polymerase, β-catenin 및 phospholipase C-γ1]의 단편화를 유도하였다. 아울러 β-lapachone은 cyclooxygenase (COX)-2의 mRNA 및 단백질의 발현을 억제하였으나 COX-1의 발현에는 영향을 미치지 않았으며, β-lapachone에 의한 COX-2의 발현억제는 prostaglandin E₂의 생성 저하에 관련이 있었다. 본 연구의 결과는 β-lapachone의 항암활성 기전의 이해와 더불어 β-lapachone이 폐암세포에서 강력한 항암활성이 있음을 보여주는 것이다.

다국어 초록 (Multilingual Abstract)

β-lapachone, a quinone of lapachol extracted from the bark of the lapacho tree, has been found to induce apoptosis in various human cancer cells. In the present study, we investigated further possible mechanisms by which β-lapachone exerts its pro-apoptotic action in cultured human lung cancer A549 cells. β-lapachone treatment resulted in inhibition of growth and induction of apoptosis in a concentration-dependent manner, as determined by MTT assay and flow cytometry analysis. The induction of apoptosis by β-lapachone was associated with up-regulation of the expression of p53 and p21 in both transcriptional and translational levels, and the phosphorylation of p53. In addition, β-lapachone activated caspase-3 and -9, and induced degradation of caspase-3 target proteins such as poly (ADP-ribose) polymerase (PARP) and β-catenin. Furthermore, β-lapachone treatment caused a progressive decrease in the expression levels of cyclooxygenase (COX)-2 without significant changes in the levels of COX-1, which was correlated with a decrease in prostaglandin E₂ synthesis. Taken together, these results indicated that β-lapachone may have therapeutic potential in human lung cancer treatment.

목차 (Table of Contents)

• 서론
• 재료 및 방법
• 결과 및 고찰
• 감사의 글
• References
• 초록

참고문헌 (Reference)

1 Schaffner-Sabba, K., "β-lapachone: synthesis of derivatives and activities in tumor models" 27 : 990-994, 1984

2 Planchon, S. M, "β-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response" 55 : 3706-3711, 1995

3 Planchon, S. M., "β-lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3" 267 : 95-106, 2001

4 Lee, J. I., "β-lapachone induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2 family and activation of caspases" 28 : 30-35, 2006

5 Huang, L., "β-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells" 5 : 711-720, 1999

6 Li, C. J., "β-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin" 268 : 22463-22468, 1993

7 Meng, R. D, "p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-γ" 262 : 154-169, 2001

8 Weller, M., "Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and β-lapachone" 73 : 707-714, 1997

9 Gately, S, "Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis" 37 : 179-192, 2003

10 Hueber, "The topoisomerase I inhibitors, camptothecin and β-lapachone, induce apoptosis of human retinal pigment epithelial cells" 67 : 525-530, 1998

11 Anderson, W. F., "The role of cyclooxygenase inhibitors in cancer prevention" 8 : 1035-1062, 2002

12 YungHyunChoi, "Suppression of Human Prostate Cancer Cell Growth by β-Lapachone via Down-regulation of pRBPhosphorylation and Induction of Cdk Inhibitor p21WAF1/CIP1" 한국생화학분자생물학회 36 (36): 223-229, 2003

13 Weller, M., "Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses" 79 : 640-644, 1998

14 Choi, Y. H., "Phosphorylation of p53, induction of Bax and activation of caspases during β-lapachone-mediated apoptosis in human prostate epithelial cells" 21 : 1293-1299, 2002

15 Pink, J. J., "NAD(P)H:Quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity" 275 : 5416-5424, 2000

16 Wuerzberger, S. M., "Induction of apoptosis in MCF-7:WS8 breast cancer cells by β-lapachone" 58 : 1876-1885, 1998

17 Don, M. J., "Induction of CDK inhibitors (p21(WAF1) and p27(Kip1)) and Bak in the β-lapachone-induced apoptosis of human prostate cancer cells." 59 : 784-794, 2001

18 Noble, J. R., "Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53" 203 : 297-304, 1992

19 Lee, J. H., "Down-regulation of cyclooxygenase-2 and telomerase activity by β-lapachone in human prostate carcinoma cells" 51 : 553-560, 2005

20 Fujita, H., "Cyclooxygenase-2 promotes prostate cancer progression" 53 : 232-240, 2002

21 Planchon, S. M., "Bcl-2 protects against β-lapachone-mediated caspase 3 activation and apoptosis in human myeloid leukemia (HL-60) cells" 6 : 485-492,

22 Moon, D. O., "Anti-inflammatory effects of β-lapachone in lipopolysaccharide-stimulated BV2 microglia" 7 : 506-514, 2007